# Methimazole Cat Dose: Feline Hyperthyroidism Dose and Monitoring


## Key Takeaways

- The standard starting dose for oral methimazole in cats is 2.5 mg administered every 12 hours (totaling 5 mg/day), with a typical maintenance range of 2.5 to 20 mg/day.
- Transdermal methimazole, applied to the inner ear pinna, offers an alternative administration route with a starting dose of 2.5 mg every 12 hours and a maintenance range of 1.0 to 15.0 mg/day, though its systemic bioavailability is lower and more variable than oral forms.
- Initial monitoring involves rechecking serum thyroxine (T4) levels at 2-3 weeks and again at 6-8 weeks, followed by every 3-6 months, alongside CBC and biochemistry to detect adverse effects like hepatopathy or hematologic abnormalities.
- Common adverse effects include gastrointestinal signs (vomiting, anorexia) and cutaneous reactions, while less common but serious effects include agranulocytosis, thrombocytopenia, and hepatopathy, necessitating prompt discontinuation of the drug.
- Methimazole treatment can unmask underlying chronic kidney disease (CKD) by normalizing glomerular filtration rate; therefore, close monitoring of renal parameters is crucial after initiating therapy.
- Alternative treatments for hyperthyroidism include radioiodine therapy, surgical thyroidectomy, and an iodine-restricted diet, with methimazole serving as a long-term medical management option.

---

[Feline hyperthyroidism](/knowledge/veterinary-medicine/clinical-methods/feline-hyperthyroidism-diagnosis-management) is the most common endocrine disorder in older cats. The cornerstone of medical management is methimazole, an antithyroid drug that blocks thyroid hormone synthesis. The standard starting dose is 2.5 mg per [cat](/knowledge/veterinary-medicine/clinical-methods/cat) administered orally every 12 hours, with a typical maintenance range of 2.5 to 20 mg per day. Close monitoring of serum thyroxine (T4) and clinical response is essential to avoid iatrogenic hypothyroidism and to manage side effects. This article provides a comprehensive, source-grounded review of methimazole dosing, monitoring protocols, and treatment goals for veterinary professionals and informed pet owners.

**Owner Triage Summary:** If your cat has been diagnosed with hyperthyroidism and prescribed methimazole, give the first dose exactly as directed by your veterinarian. Do not adjust the dose without veterinary guidance. Watch for signs of vomiting, reduced appetite, lethargy, facial itching, or bleeding. These can indicate adverse drug reactions requiring immediate veterinary attention. If your cat refuses to eat or becomes severely lethargic, contact your veterinary clinic the same day. Never stop the medication abruptly without consulting your veterinarian, as thyroid hormone levels can rapidly rise again.

## At a Glance: Methimazole Dosing and Monitoring

| Parameter | Oral Methimazole | Transdermal Methimazole |
| :--- | :--- | :--- |
| **Typical Starting Dose** | 2.5 mg/cat PO q12h (5 mg/day) | 2.5 mg/cat applied to inner pinna q12h |
| **Maintenance Dose Range** | 2.5 to 20 mg/day total, divided q12h [<a href="#ref-1">1</a>] | 1.0 to 15.0 mg/day [<a href="#ref-2">2</a>] |
| **Route of Administration** | Tablet given orally | Gel applied to inner ear pinna |
| **Time to Initial T4 Suppression** | Significant decrease by 2-3 weeks [<a href="#ref-1">1</a>] | Significant decrease by 1-2 weeks [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>] |
| **Monitoring Frequency** | Recheck T4 at 2-3 weeks, then every 3-6 months | Recheck T4 at 2-4 weeks, then every 3-6 months |
| **Common Side Effects** | Vomiting, anorexia, lethargy, bleeding diathesis, hepatopathy [<a href="#ref-1">1</a>] | Cutaneous reactions, mild gastrointestinal signs [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>] |
| **Key Advantage** | Well-established efficacy and predictable absorption [<a href="#ref-1">1</a>] | Easier for owners to administer; avoids pilling [<a href="#ref-2">2</a>] |

## Understanding Feline Hyperthyroidism

Hyperthyroidism results from a functional thyroid adenoma or adenomatous hyperplasia, leading to excessive secretion of thyroxine (T4) and triiodothyronine (T3). This excess hormone accelerates the cat's metabolism, causing clinical signs such as weight loss despite a good appetite, polyphagia, polydipsia, polyuria, vomiting, diarrhoea, hyperactivity, and a palpable thyroid nodule. The disease is progressive if left untreated, leading to cardiac complications and renal damage.

Methimazole is a thioureylene antithyroid drug that inhibits the thyroid peroxidase enzyme, thereby blocking the iodination of tyrosine residues and the coupling of iodotyrosines to form T4 and T3. It does not affect the release of preformed thyroid hormones, which is why clinical improvement and serum T4 reduction take several days to weeks to become apparent. The drug is well absorbed orally, but its bioavailability via the transdermal route is significantly lower and more variable [<a href="#ref-5">5</a>].

## Methimazole Cat Dose: Oral Formulation

### Starting Dose

The classic starting dose for oral methimazole is 2.5 mg per cat given twice daily (q12h), totaling 5 mg per day. This is based on the landmark study by Peterson et al., which used 10 to 15 mg/day divided into two or three doses for the first 2 to 3 weeks [<a href="#ref-1">1</a>]. Most clinicians begin with the lower 5 mg/day dose to minimize the risk of gastrointestinal side effects and allow for a gradual adjustment based on the cat's T4 response.

### Dose Titration

After 2 to 3 weeks of therapy, serum T4 should be re-evaluated. In the study of 262 hyperthyroid cats, the mean serum T4 concentration decreased significantly from a pretreatment value of 12.1 micrograms/dl to 2.1 micrograms/dl after 2 to 3 weeks of methimazole (10 to 15 mg/day) [<a href="#ref-1">1</a>]. The goal is to achieve a T4 concentration within the reference interval, ideally in the lower half to minimize the risk of iatrogenic hypothyroidism.

The final maintenance dose for cats treated solely with methimazole ranged from 2.5 to 20 mg/day, with a mean of 11.9 mg/day [<a href="#ref-1">1</a>]. This wide range highlights the need for individualised dosing. If the T4 remains elevated after 3 weeks, the dose can be increased by 2.5 to 5 mg/day. Conversely, if the T4 falls below the reference interval or the cat shows clinical signs of hypothyroidism (lethargy, weight gain, poor hair coat), the dose should be reduced.

### Maximum Dose

The maximum recommended oral dose is generally 20 mg/day. Doses above this are rarely needed and increase the risk of adverse effects. In the Peterson study, the highest maintenance dose used was 20 mg/day [<a href="#ref-1">1</a>]. If a cat requires more than 20 mg/day to control hyperthyroidism, alternative treatments such as radioiodine or thyroidectomy should be strongly considered.

## Methimazole Cat Dose: Transdermal Formulation

Transdermal methimazole is a valuable alternative for cats that are difficult to pill. It is formulated in a pluronic lecithin organogel (PLO) or a similar lipophilic vehicle and applied to the inner surface of the pinna (ear flap). The starting dose is typically 2.5 mg per cat applied to the inner ear every 12 hours.

### Efficacy and Absorption

A prospective study by Lécuyer et al. treated 13 newly diagnosed hyperthyroid cats with transdermal methimazole at 5 mg (0.1 mL of a 50 mg/mL solution) applied to the inner ear pinna every 12 hours for 28 days. Ten cats completed the study, and all showed clinical improvement with a significant decrease in serum T4. The mean T4 dropped from 97.31 nmol/L at day 0 to 27.44 nmol/L at day 14 and 14.63 nmol/L at day 28 [<a href="#ref-3">3</a>]. This confirms that transdermal methimazole is an effective alternative to oral therapy.

However, the absorption of transdermal methimazole is poor and variable compared to oral administration. In a pharmacokinetic study by Hoffman et al., the absolute bioavailability of transdermal methimazole in a PLO gel was only 11.4%, compared to oral administration [<a href="#ref-5">5</a>]. Only two of six healthy cats achieved detectable serum methimazole concentrations after transdermal application. Despite this low systemic bioavailability, clinical studies show that it is effective, likely because the drug accumulates in the thyroid gland.

### Long-Term Use

A long-term follow-up study by Boretti et al. evaluated 60 hyperthyroid cats treated with transdermal methimazole for a median of 22.6 months (range 3.6 to 88.4 months). The starting dose was 2.5 mg/cat q12h, and the maximal and minimal daily doses during the follow-up period were 15.0 mg and 1.0 mg, respectively [<a href="#ref-2">2</a>]. The study found that doses often needed to be increased over time, especially after 24 to 36 months of therapy, to maintain euthyroidism. This highlights the importance of regular monitoring and dose adjustment, even in cats that have been stable for years.

### Duration of T4 Suppression

A study by Boretti et al. examined the duration of T4 suppression after transdermal methimazole application. Cats were treated with either 2.5 mg q12h or 5 mg q24h. Both groups showed sustained suppression of T4 concentration during the 10-hour post-application period, and T4 concentrations immediately before the next dose were not significantly different from any time point after application [<a href="#ref-4">4</a>]. This suggests that the timing of blood sampling for T4 measurement is not critical when using transdermal methimazole, as the suppression is relatively constant throughout the dosing interval.

### Application Site

The inner pinna is the recommended application site for transdermal methimazole. In vitro studies have shown that methimazole is absorbed more completely across pinnal skin compared to the groin, neck, or thorax [<a href="#ref-6">6</a>]. Furthermore, methimazole can cross from the inner to the outer pinna, which may contribute to systemic absorption and also explains why some cats develop local skin reactions [<a href="#ref-7">7</a>]. Owners should alternate ears for each dose to minimize local irritation.

## Monitoring Protocols

### Initial Monitoring (First 3 Months)

Monitoring is critical to ensure efficacy and detect adverse effects early. The American Animal Hospital Association (AAHA) and the American Veterinary Medical Association (AVMA) endorse regular monitoring for cats on chronic medication. The following protocol is based on the evidence from the approved sources:

1.  **Baseline (Day 0):** Obtain a complete blood count (CBC), serum biochemistry profile, urinalysis, and serum T4 concentration before starting methimazole. This establishes a baseline and screens for concurrent diseases, especially chronic kidney disease (CKD), which is common in older hyperthyroid cats.
2.  **Week 2-3:** Recheck serum T4 concentration. For oral methimazole, the goal is a significant decrease in T4, ideally into the reference interval [<a href="#ref-1">1</a>]. For transdermal methimazole, a significant decrease is also expected by this time [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. A CBC and biochemistry panel should be repeated to monitor for haematologic or hepatic side effects.
3.  **Week 6-8:** Recheck serum T4, CBC, and biochemistry. This is particularly important to detect delayed side effects such as thrombocytopenia, leukopenia, or hepatopathy, which typically occur within the first 2 months of therapy [<a href="#ref-1">1</a>].
4.  **Month 3:** Recheck serum T4 and renal parameters. At this point, the cat should be stable, and the dose should be adjusted to maintain T4 in the lower half of the reference interval.

### Long-Term Monitoring (Every 3-6 Months)

Once the cat is stable, monitoring can be reduced to every 3 to 6 months. Each visit should include a serum T4 measurement and a biochemistry panel to assess renal function. Blood pressure measurement and urinalysis are also recommended to monitor for hypertension and proteinuria, which are common complications of hyperthyroidism and its treatment.

### Adjusting the Dose Based on T4

- **T4 above the reference interval:** The dose should be increased by 2.5 to 5 mg/day, and T4 rechecked in 2 to 3 weeks.
- **T4 in the upper half of the reference interval:** The dose is likely adequate, but the cat should be monitored for clinical signs of hyperthyroidism.
- **T4 in the lower half of the reference interval:** This is the ideal target for most cats, as it minimises the risk of iatrogenic hypothyroidism while controlling the disease.
- **T4 below the reference interval:** The dose should be reduced by 2.5 mg/day, and the cat monitored for signs of hypothyroidism (lethargy, weight gain, poor coat).

## Adverse Effects and Management

Methimazole is generally well-tolerated, but adverse effects are not uncommon. In the Peterson study, clinical side effects developed in 48 of 262 cats (18.3%), usually within the first month of therapy. These included anorexia, vomiting, lethargy, self-induced excoriation of the face and neck, bleeding diathesis, and icterus caused by hepatopathy [<a href="#ref-1">1</a>].

### Gastrointestinal Signs

Vomiting, anorexia, and diarrhoea are the most common gastrointestinal side effects. These are often transient and may resolve without intervention. If they persist, options include reducing the dose, switching to transdermal administration, or dividing the daily dose into smaller, more frequent administrations.

### Haematologic Abnormalities

Mild haematologic abnormalities developed in 43 of 262 cats (16.4%), usually within the first 2 months of treatment. These included eosinophilia, lymphocytosis, and slight leukopenia [<a href="#ref-1">1</a>].

More serious haematologic reactions, including agranulocytosis and thrombocytopenia (associated with bleeding), developed in 10 cats (3.8%) [<a href="#ref-1">1</a>]. These are potentially life-threatening and require immediate discontinuation of the drug. A CBC should be performed if a cat develops fever, lethargy, or signs of bleeding (petechiae, ecchymoses, melena) while on methimazole.

### Cutaneous Reactions

Self-induced excoriation of the face and neck is a characteristic side effect of methimazole in cats. It is thought to be a hypersensitivity reaction. In the transdermal study by Lécuyer et al., one cat showed a cutaneous adverse reaction along with marked thrombocytopenia [<a href="#ref-3">3</a>]. In the long-term transdermal study, erythema of the pinna was noted in two cats, necessitating a switch to oral medication [<a href="#ref-2">2</a>]. If a cutaneous reaction occurs, the drug should be discontinued or the route changed.

### Hepatopathy

Icterus caused by hepatopathy is a serious adverse effect. It is characterised by elevated liver enzymes and bilirubin. If this occurs, methimazole should be discontinued, and supportive care initiated.

### Managing Side Effects

The management of side effects depends on their severity. Mild gastrointestinal signs may be managed by giving the medication with food or switching to transdermal administration. More serious reactions, such as haematologic abnormalities, hepatopathy, or severe cutaneous reactions, require immediate discontinuation of the drug. In such cases, alternative treatments for hyperthyroidism, such as radioiodine or thyroidectomy, should be considered.

## Special Considerations

### Chronic Kidney Disease

Hyperthyroidism can mask underlying chronic kidney disease (CKD) by increasing glomerular filtration rate (GFR). When methimazole is started and T4 levels normalise, GFR decreases, which can unmask pre-existing renal insufficiency. This is a common clinical scenario. Therefore, it is essential to monitor renal parameters (creatinine, urea, urine specific gravity) closely after initiating methimazole therapy. If azotaemia develops, the dose of methimazole may need to be reduced, or the treatment plan may need to be reassessed.

### Radioiodine Therapy

Radioiodine (131I) is a definitive treatment for hyperthyroidism. Cats are typically taken off methimazole for at least 1 week before 131I therapy [<a href="#ref-8">8</a>, <a href="#ref-9">9</a>]. The methimazole dose does not directly influence the 131I dose, but the cat's thyroid status and renal function are important considerations. Individualised dosing algorithms for 131I have been developed to minimise the risk of iatrogenic hypothyroidism and azotaemia [<a href="#ref-8">8</a>, <a href="#ref-9">9</a>]. For cats that are poor candidates for surgery or radioiodine, long-term methimazole is a viable option.

### Iodine-Restricted Diet

An iodine-restricted diet is another management option for hyperthyroidism. It works by limiting the dietary iodine available for thyroid hormone synthesis. If a cat is switched from methimazole to an iodine-restricted diet, the methimazole should be tapered and discontinued to prevent iatrogenic hypothyroidism.

## Limitations and When to Contact a Veterinarian

This article provides general guidelines based on published studies. It cannot predict individual responses to methimazole. Breed, age, concurrent diseases, and individual metabolism can all influence the effective dose and the risk of side effects. For example, a cat with pre-existing CKD may require a lower dose of methimazole to avoid worsening renal function. Similarly, a cat with a large thyroid adenoma may require a higher dose.

You should contact your veterinarian immediately if you observe any of the following:

- Vomiting or diarrhoea that persists for more than 24 hours.
- Loss of appetite (anorexia) lasting more than 24 hours.
- Lethargy or weakness.
- Bleeding from the nose, gums, or in the stool.
- Redness, swelling, or itching of the skin, especially the face and neck.
- Yellowing of the gums, skin, or eyes (icterus).
- Difficulty breathing.

These signs may indicate a serious adverse reaction to methimazole and require prompt veterinary attention.

## Unsafe Home Remedies and Over-the-Counter Products

There are no safe or effective home remedies for feline hyperthyroidism. Over-the-counter supplements or herbal products are not recommended and may be harmful. Black walnut oil has been studied in rats with methimazole-induced hypothyroidism, but this is a model of hypothyroidism, not hyperthyroidism, and its relevance to cats is unknown [<a href="#ref-10">10</a>]. Never administer any human thyroid medication or supplement to your cat. The only safe and evidence-based treatments for hyperthyroidism are methimazole, an iodine-restricted diet, surgical thyroidectomy, and radioiodine therapy.

## Prognosis

With appropriate monitoring and dose adjustment, the prognosis for cats with hyperthyroidism treated with methimazole is good. Many cats live for years on this medication. However, the disease is progressive, and the dose may need to be increased over time [<a href="#ref-2">2</a>]. The development of adverse effects or the unmasking of CKD can complicate management. Regular veterinary check-ups are essential to ensure the best possible outcome.

## Frequently Asked Questions

### What is the starting dose of methimazole for a cat?
The typical starting dose of oral methimazole is 2.5 mg per cat given every 12 hours, totaling 5 mg per day. For transdermal methimazole, the starting dose is also 2.5 mg applied to the inner ear every 12 hours.

### How long does it take for methimazole to lower a cat's T4?
A significant decrease in serum T4 is typically seen within 2 to 3 weeks of starting oral methimazole therapy. For transdermal methimazole, a significant decrease is also observed within 1 to 2 weeks.

### What is the maximum daily dose of methimazole for a cat?
The maximum recommended daily dose of methimazole for a cat is 20 mg. Most cats are maintained on a dose between 2.5 and 20 mg per day.

### Can I give my cat methimazole once a day?
While once-daily dosing is possible for some cats, the standard recommendation is to divide the total daily dose into two administrations (every 12 hours) to maintain more consistent blood levels and reduce the risk of gastrointestinal side effects. Some studies have evaluated once-daily transdermal dosing, but twice-daily is more commonly recommended.

### What are the most common side effects of methimazole in cats?
The most common side effects include vomiting, anorexia, and lethargy, which occur in about 18% of cats. More serious side effects include bleeding disorders, liver toxicity, and skin excoriation.

### How often should a cat on methimazole be monitored?
A cat on methimazole should have serum T4 and a biochemistry panel rechecked at 2 to 3 weeks after starting therapy, again at 6 to 8 weeks, and then every 3 to 6 months once stable.

### What should I do if I miss giving my cat a dose of methimazole?
If you miss a dose, give it as soon as you remember. If it is almost time for the next dose, skip the missed dose and resume the normal schedule. Do not give a double dose.

### Can methimazole be used long-term in cats?
Yes, methimazole can be used as a long-term treatment for hyperthyroidism. Some cats have been successfully managed for several years. However, the dose may need to be adjusted over time, and regular monitoring is essential.

## Veterinary Disclaimer

This article is educational and is not a substitute for veterinary diagnosis or treatment. Always consult with your veterinarian before starting, stopping, or changing any medication for your cat. The information provided here is based on published research and clinical guidelines, but individual cases may vary.


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What is the starting dose of methimazole for a cat?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The typical starting dose of oral methimazole is 2.5 mg per cat given every 12 hours, totaling 5 mg per day. For transdermal methimazole, the starting dose is also 2.5 mg applied to the inner ear every 12 hours."
      }
    },
    {
      "@type": "Question",
      "name": "How long does it take for methimazole to lower a cat's T4?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A significant decrease in serum T4 is typically seen within 2 to 3 weeks of starting oral methimazole therapy. For transdermal methimazole, a significant decrease is also observed within 1 to 2 weeks."
      }
    },
    {
      "@type": "Question",
      "name": "What is the maximum daily dose of methimazole for a cat?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The maximum recommended daily dose of methimazole for a cat is 20 mg. Most cats are maintained on a dose between 2.5 and 20 mg per day."
      }
    },
    {
      "@type": "Question",
      "name": "Can I give my cat methimazole once a day?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "While once-daily dosing is possible for some cats, the standard recommendation is to divide the total daily dose into two administrations (every 12 hours) to maintain more consistent blood levels and reduce the risk of gastrointestinal side effects. Some studies have evaluated once-daily transdermal dosing, but twice-daily is more commonly recommended."
      }
    },
    {
      "@type": "Question",
      "name": "What are the most common side effects of methimazole in cats?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The most common side effects include vomiting, anorexia, and lethargy, which occur in about 18% of cats. More serious side effects include bleeding disorders, liver toxicity, and skin excoriation."
      }
    },
    {
      "@type": "Question",
      "name": "How often should a cat on methimazole be monitored?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A cat on methimazole should have serum T4 and a biochemistry panel rechecked at 2 to 3 weeks after starting therapy, again at 6 to 8 weeks, and then every 3 to 6 months once stable."
      }
    },
    {
      "@type": "Question",
      "name": "What should I do if I miss giving my cat a dose of methimazole?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "If you miss a dose, give it as soon as you remember. If it is almost time for the next dose, skip the missed dose and resume the normal schedule. Do not give a double dose."
      }
    },
    {
      "@type": "Question",
      "name": "Can methimazole be used long-term in cats?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, methimazole can be used as a long-term treatment for hyperthyroidism. Some cats have been successfully managed for several years. However, the dose may need to be adjusted over time, and regular monitoring is essential."
      }
    }
  ]
}
</script>

## Sources

<a id="ref-1"></a>[<a href="#ref-1">1</a>] [Methimazole treatment of 262 cats with hyperthyroidism.](https://pubmed.ncbi.nlm.nih.gov/3265728/)

<a id="ref-2"></a>[<a href="#ref-2">2</a>] [Transdermal application of methimazole in hyperthyroid cats: a long-term follow-up study.](https://pubmed.ncbi.nlm.nih.gov/24174499/)

<a id="ref-3"></a>[<a href="#ref-3">3</a>] [Clinical efficacy and safety of transdermal methimazole in the treatment of feline hyperthyroidism.](https://pubmed.ncbi.nlm.nih.gov/16579038/)

<a id="ref-4"></a>[<a href="#ref-4">4</a>] [Duration of t4 suppression in hyperthyroid cats treated once and twice daily with transdermal methimazole.](https://pubmed.ncbi.nlm.nih.gov/23398124/)

<a id="ref-5"></a>[<a href="#ref-5">5</a>] [Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats.](https://pubmed.ncbi.nlm.nih.gov/12081614/)

<a id="ref-6"></a>[<a href="#ref-6">6</a>] [Regional variations in percutaneous absorption of methimazole: an in vitro study on cat skin.](https://pubmed.ncbi.nlm.nih.gov/25728360/)

<a id="ref-7"></a>[<a href="#ref-7">7</a>] [Trans-pinnal movement of methimazole: an in vitro study showing that methimazole can cross from the inner to outer pinna of cats.](https://pubmed.ncbi.nlm.nih.gov/25600079/)

<a id="ref-8"></a>[<a href="#ref-8">8</a>] [Radioiodine treatment of hyperthyroidism in cats: results of 165 cats treated by an individualised dosing algorithm in Spain.](https://pubmed.ncbi.nlm.nih.gov/35748791/)

<a id="ref-9"></a>[<a href="#ref-9">9</a>] [A dosing algorithm for individualized radioiodine treatment of cats with hyperthyroidism.](https://pubmed.ncbi.nlm.nih.gov/34351027/)

<a id="ref-10"></a>[<a href="#ref-10">10</a>] [The Impact of Black Walnut (Juglans nigra) Oil on Male Wistar Rats Suffering from Methimazole-Induced Hypothyroidism.](https://pubmed.ncbi.nlm.nih.gov/41104254/)

<a id="ref-11"></a>[<a href="#ref-11">11</a>] [The effect of methimazole on thyroid uptake of pertechnetate and radioiodine in normal cats.](https://pubmed.ncbi.nlm.nih.gov/11678569/)

<a id="ref-12"></a>[<a href="#ref-12">12</a>] [COMPUTED TOMOGRAPHIC CHARACTERISTICS OF THE THYROID GLANDS IN EIGHT HYPERTHYROID CATS PRE- AND POSTMETHIMAZOLE TREATMENT COMPARED WITH SEVEN EUTHYROID CATS.](https://pubmed.ncbi.nlm.nih.gov/27918152/)

<a id="ref-13"></a>[<a href="#ref-13">13</a>] [An online survey to determine owner experiences and opinions on the management of their hyperthyroid cats using oral anti-thyroid medications.](https://pubmed.ncbi.nlm.nih.gov/23591627/)

<a id="ref-14"></a>[<a href="#ref-14">14</a>] [Iodide induced suppression of thyrotropin-stimulated adenosine 3',5'-monophosphate production in cat thyroid slices.](https://pubmed.ncbi.nlm.nih.gov/210098/)

## Related Clinical & Scientific Guides

* [Drontal Plus Dewormer: Broad-Spectrum Dose Guide by Weight](/knowledge/veterinary-medicine/calculators-clinical-tools/drontal-plus-dewormer-broad-spectrum-dose-guide-by-weight)
* [Panacur Fenbendazole Dewormer: Dog Fecal Parasite Treatment Schedule](/knowledge/veterinary-medicine/calculators-clinical-tools/panacur-fenbendazole-dewormer-dog-fecal-parasite-treatment-schedule)
* [Prednisolone for Cats: Feline Safe Steroid Dose and Autoimmune](/knowledge/veterinary-medicine/calculators-clinical-tools/prednisolone-for-cats-feline-safe-steroid-dose-and-autoimmune)